Aerovate Therapeutics, Inc. (AVTE)

Aerovate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.12	23.49	22.4	54.2	4.57	3.51
Short-Term Investments	57.62	98.95	106.82	113.18	-	-
Cash & Short-Term Investments	88.73	122.44	129.22	167.38	4.57	3.51
Cash Growth	-34.37%	-5.25%	-22.80%	3560.07%	30.14%	-
Prepaid Expenses	0.99	1.54	1.98	6.72	0.07	-
Other Current Assets	0.88	0.25	0.3	0.24	0.04	-
Total Current Assets	90.61	124.23	131.5	174.33	4.68	3.51
Property, Plant & Equipment	0.27	0.9	1.25	0.73	0.04	-
Other Long-Term Assets	0.08	2.28	2.56	0.3	-	-
Total Assets	90.96	127.42	135.3	175.36	4.72	3.51
Accounts Payable	0.91	2.4	2.58	1.21	0.61	0.54
Accrued Expenses	8.66	13.73	4.44	1.01	1.14	0.11
Current Portion of Leases	0.46	0.42	0.39	0.19	-	-
Other Current Liabilities	0.29	1.09	0.38	0.14	0.02	0
Total Current Liabilities	10.32	17.64	7.78	2.55	1.77	0.66
Long-Term Debt	-	-	-	-	-	2.5
Long-Term Leases	0.08	0.26	0.71	0.38	-	-
Other Long-Term Liabilities	0.07	0.07	0.07	0.01	-	-
Total Liabilities	10.47	17.96	8.56	2.95	1.77	3.16
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	307.89	272.64	215.11	208.87	0.06	-
Retained Earnings	-227.62	-163.42	-87.9	-36.39	-13.41	-3.64
Comprehensive Income & Other	0.22	0.24	-0.47	-0.06	-	-
Total Common Equity	80.49	109.46	126.74	172.42	-13.34	-3.64
Shareholders' Equity	80.49	109.46	126.74	172.42	2.94	0.36
Total Liabilities & Equity	90.96	127.42	135.3	175.36	4.72	3.51
Total Debt	0.54	0.68	1.09	0.57	-	2.5
Net Cash (Debt)	88.19	121.76	128.13	166.8	4.57	1.01
Net Cash Growth	-34.38%	-4.97%	-23.18%	3547.52%	350.99%	-
Net Cash Per Share	3.11	4.62	5.24	13.57	18.88	4.20
Filing Date Shares Outstanding	28.87	27.86	24.81	24.41	0.24	0.24
Total Common Shares Outstanding	28.87	27.76	24.72	24.41	0.24	0.24
Working Capital	80.29	106.6	123.71	171.78	2.9	2.86
Book Value Per Share	2.79	3.94	5.13	7.06	-54.90	-15.09
Tangible Book Value	80.49	109.46	126.74	172.42	-13.34	-3.64
Tangible Book Value Per Share	2.79	3.94	5.13	7.06	-54.90	-15.09

Source: S&P Capital IQ. Standard template. Financial Sources.